No, Latanoprost Should Not Be Taken Twice Daily
Latanoprost must be dosed once daily in the evening only—twice daily dosing is explicitly contraindicated as it decreases efficacy and may paradoxically elevate intraocular pressure. 1
FDA-Approved Dosing
The FDA label is unequivocal: latanoprost dosage should not exceed once daily, and administration more than once daily may:
- Decrease the intraocular pressure (IOP) lowering effect
- Cause paradoxical elevations in IOP 1
The recommended dose is one drop (1.5 μg) in the affected eye(s) once daily in the evening. If a dose is missed, simply continue with the next scheduled evening dose—do not double up. 1
Why Once Daily Is Superior: The Evidence
Receptor Subsensitivity Mechanism
Multiple high-quality studies demonstrate that twice daily dosing is consistently less effective than once daily dosing:
- Once daily (50 μg/ml) reduces IOP by 7.5 mmHg vs. twice daily (15 μg/ml) reducing IOP by only 6.1 mmHg (p < 0.001) 2
- In normal-pressure glaucoma patients, once daily achieved 21.3% IOP reduction vs. only 14.2% with twice daily (p = 0.001) 3
- A mechanistic study in healthy volunteers showed once daily dosing resulted in significantly lower IOP compared to twice daily on day 15 (p < 0.001), with the difference persisting even when no morning dose was given 4
The reduced efficacy with twice daily dosing appears to result from FP-receptor subsensitivity or downregulation of intracellular signaling pathways—this effect is reversible when returning to once daily dosing. 4
Clinical Trial Data
A 2023 crossover study attempted to evaluate twice daily dosing of latanoprost/timolol fixed combination and found:
- While twice daily showed statistically lower mean IOP (12.49 vs. 13.48 mmHg), the absolute IOP reduction was not significantly different
- Patients switched from twice daily back to once daily had significantly higher IOP (1.25 mmHg increase, p = 0.006)
- Twice daily dosing caused more ocular side effects 5
Guideline Recommendations
The 2021 American Academy of Ophthalmology Primary Open-Angle Glaucoma guidelines explicitly state that prostaglandin analogs need to be instilled only once daily, which is a key reason they are the most frequently prescribed and preferred first-line therapy for glaucoma. 6
Common Pitfalls to Avoid
- Do not instruct patients to use twice daily if once daily is insufficient—instead, add a second medication from a different class or consider laser trabeculoplasty
- Do not combine two prostaglandins or prostaglandin analogs—this is not recommended per FDA labeling 1
- Timing matters: Evening dosing is standard as IOP reduction starts 3-4 hours after administration with maximum effect at 8-12 hours 1
- If using multiple topical medications, separate administration by at least 5 minutes 1
What to Do If Once Daily Is Inadequate
If target IOP is not achieved with once daily latanoprost:
- Add a medication from a different class (beta-blocker, alpha-2 agonist, carbonic anhydrase inhibitor, or rho kinase inhibitor)
- Consider selective laser trabeculoplasty, which has comparable efficacy to prostaglandin analogs 7
- Reassess target IOP—a 20% reduction from baseline may be insufficient if baseline pressure was markedly elevated 6